Sign inJoin waitlistJoin the waitlist

RK

Ryan Kopp

Associate Professor of Urology, School of Medicine · Oregon Health & Science University

Credentials: · · ·

History

Oregon Health & Science University
Present

Memorial Sloan Kettering Cancer Center
2014–2015
Urology
University of California (San Diego) Medical Center
2008–2013
Indiana University School of Medicine
2003–2007

Research

Peroxisome proliferator-activated receptor coactivator-1alpha (PGC-1alpha) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-alpha and -gamma.…
Journal of Biological Chemistry · 2002 · 426 citations
Survival outcomes after radical and partial nephrectomy for clinical T2 renal tumours categorised by R.E.N.A.L. nephrometry score
BJU international · 2014 · First of 11 authors · 109 citations
Feasibility and efficacy of neoadjuvant sunitinib before nephron-sparing surgery
BJU international · 2010 · 86 citations

Ithaar Derweesh
24 papers
Reza Mehrazin
13 papers · 8 as a resident
Anthony Patterson
12 papers
Michael Liss
11 papers
Sean Stroup
11 papers
Christopher Kane
10 papers
MG
Mark Garzotto
10 papers
WB
Wassim Bazzi
10 papers · 10 as a resident
Christopher Amling
6 papers
Ramzi Jabaji
6 papers · 2 as a resident
HL
Hak Lee
5 papers
JP
John Parsons
5 papers

Grants

Precision Neoadjuvant Therapy for High Risk Localized Prostate Cancer with PTEN Loss
Department of Veterans Affairs · I01
Contact PI · Portland Va Medical Center
2024–2028

Clinical trials

A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
Principal investigator · Recruiting · Phase 2
VA Office of Research and Development
2024–2027
Enzalutamide Implants (Enolen) in Patients With Prostate Cancer
Site PI · Recruiting · Phase 1
Alessa Therapeutics Inc.
2024–2028